Editing Around the Target: Epitope Engineering to Protect Stem Cell Grafts

Area of Science:

• Hematology
• Immunotherapy
• Gene Editing

Background:

• Targeted immunotherapies show promise for hematologic malignancies but face challenges with on-target, off-tumor toxicity due to shared antigen expression.
• Previous strategies like antigen knockout in hematopoietic stem and progenitor cells (HSPCs) were limited to dispensable markers.

Purpose of the Study:

• To review advances in epitope engineering for hematopoietic stem cells (HSCs) using base and prime editing.
• To explore preclinical and translational studies of epitope editing in hematologic conditions.
• To discuss challenges and future directions for safe and effective HSC epitope editing.

Main Methods:

• Review of recent literature on base and prime editing techniques for epitope modification in HSCs.
• Analysis of preclinical and translational studies investigating epitope engineering in hematologic contexts.
• Discussion of challenges including editing efficiency, off-target effects, delivery, and long-term safety.

Main Results:

• Epitope engineering offers a way to modify target antigens on healthy cells, decoupling therapeutic susceptibility from physiological function.
• Base and prime editing are key technologies enabling precise antigen modification in HSCs.
• Emerging studies show potential for epitope engineering in both malignant and non-malignant hematologic conditions.

Conclusions:

• Epitope engineering of HSCs expands the therapeutic window for precision immunotherapies.
• This versatile platform may enable safer, more effective combinatorial treatments for hematologic disorders.
• Addressing challenges in editing efficiency, delivery, and safety is crucial for clinical translation.